Shimadzu to License Qiagen Genomics SNP Technology

Jun 13, 2001

NEW YORK, June 13 – The life sciences division of Shimadzu has agreed to purchase Qiagen Genomics’ SNP analysis platform and license the technology, the companies said Wednesday.

The non-exclusive agreement calls for Shimadzu to purchase Qiagen Genomics’ genotyping chemistry and instrumentation for five years. Shimadzu of Japan will use the equipment to provide genotyping services to Japanese customers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu